Example: Heart Attack

Search clinical trials for: Didanosine

Total 151 results

NCT02251873

Completed

Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers

Conditions: Healthy
NCT01605084

Withdrawn

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Conditions: HIV
NCT01440569

Completed

Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults

Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
NCT01363011

Completed

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Conditions: Acquired Immunodeficiency Syndrome; HIV Infections
NCT00955968

Completed

IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

Conditions: HIV Infection
NCT00928187

Completed

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Conditions: HIV; HIV Infections
NCT00708162

Completed

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Conditions: HIV Infection
NCT00703586

Completed

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Conditions: HIV Infections
NCT00668356

Suspended

Bioequivalence Study of Didanosine in Children Treated for HIV

Conditions: HIV Infections
NCT00642291

Completed

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Conditions: HIV Infections
NCT00618176

Completed

Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation Cohort

Conditions: HIV Infections
NCT00476606

Recruiting

A Prospective Cohort of Children With HIV Infection

Conditions: HIV Infections
NCT00427297

Terminated

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Conditions: HIV Infections
NCT00364793

Completed

Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children

Conditions: HIV Infections
NCT00358696

Completed

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Conditions: HIV; HIV Infections
NCT00342355

Completed

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Conditions: HIV
NCT00338390

Completed

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

Conditions: HIV Infections
NCT00332306

Unknown status

Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis Treatment

Conditions: Tuberculosis; Human Immunodeficiency Virus Infections
NCT00256828

Completed

Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV

Conditions: HIV Infections
NCT00214435

Unknown status

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Conditions: HIV Infection; AIDS
NCT00207168

Completed

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Conditions: AIDS
NCT00196599

Completed

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Conditions: HIV Infections; Antiretroviral Naive
NCT00196612

Completed

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Conditions: HIV Infections
NCT00197613

Completed

The Adult Antiretroviral Treatment and Resistance Study (Tshepo)

Conditions: AIDS; HIV Infection
NCT00192660

Completed

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Conditions: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease
NCT00158470

Completed

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Conditions: HIV Infection
NCT00142337

Completed

One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose Nevirapine

Conditions: HIV Infections
NCT00135382

Completed

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Conditions: HIV Infections
NCT00122538

Completed

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Conditions: HIV Infections; AIDS
NCT00116415

Completed

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Conditions: HIV Infections; AIDS
NCT00109590

Completed

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Conditions: HIV Infections
NCT00102960

Completed

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Conditions: HIV Infections
NCT00091936

Completed

Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings

Conditions: HIV Infections; Tuberculosis
NCT00002905

Unknown status

Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma

Conditions: Lymphoma
NCT00084136

Completed

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Conditions: HIV Infections
NCT00080522

Completed

Strategies for Delivering Anti-HIV Therapy in South Africa

Conditions: HIV Infections
NCT00074581

Completed

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Conditions: HIV Infections
NCT00051090

Withdrawn

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Conditions: HIV Infections; Hepatitis B
NCT00001267

Completed

A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine

Conditions: AIDS-Related Complex; Acquired Immunodeficiency Syndrome
NCT00001818

Completed

Combination Drug Treatment of Pediatric HIV Infection

Conditions: HIV Infection
NCT00034086

Completed

Study of Anti-HIV Therapy Intensification

Conditions: HIV Infections
NCT00026676

Completed

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

Conditions: HIV Infection
NCT00000625

Completed

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

Conditions: HIV Infections
NCT00000637

Completed

A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children

Conditions: HIV Infections
NCT00000652

Completed

A Phase I Study to Evaluate the Safety and Toxicity of the Combination of Zidovudine and 2',3'-Dideoxyinosine (Didanosine) in Children With HIV Infection

Conditions: HIV Infections
NCT00000656

Completed

A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease

Conditions: HIV Infections
NCT00000657

Completed

Comparison of 2',3'-Dideoxyinosine (Didanosine, ddI) and Zidovudine in Therapy of Patients With the AIDS Dementia Complex

Conditions: AIDS Dementia Complex; HIV Infections
NCT00000669

Completed

A Phase I Safety and Pharmacokinetics Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Infants and Children With AIDS or Symptomatic HIV Infection

Conditions: HIV Infections
NCT00000671

Completed

A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment

Conditions: HIV Infections
NCT00000672

Completed

An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex

Conditions: HIV Infections

COOKIE SETTINGS

Search clinical trials for: Didanosine